Literature DB >> 6431199

Biologic properties of factor-independent nonadherent hematopoietic and adherent preadipocyte cell lines derived from continuous bone marrow culture.

J S Greenberger, M A Sakakeeny, L M Davis, W C Moloney, D Reid.   

Abstract

Cell lines dependent for growth upon an inducer T-cell synthesized glycoprotein factor interleukin-3 have been derived from continuous mouse bone marrow cultures. These factor-dependent (FD) lines have been shown to be multipotential (erythroid/basophil/neutrophil) or (eosinophil/basophil/neutrophil); or are unipotent basophil or neutrophil granulocyte cell lines. Both classes of cloned FD lines have maintained self-renewal in vitro for several years with absolute growth dependence on freshly added IL-3. In four instances, factor-independent (FI) variant cell lines were derived, one by subculture in medium containing hydrocortisone and 25% horse serum and three by evolution of variants from cloned FD lines. One class of (FI) lines demonstrated adherent fibroblast-like morphology with differentiation to differentiated adipocytes in medium containing 10(-5) hydrocortisone. A second class of cell lines evolved from cloned FD lines and each grew in suspension culture to a saturation density over 10-fold greater than that for the parent FD line (greater than 10(7)/ml) and each contained no detectable hematopoietic cellular differentiation markers by histochemistry or cell surface receptors. In contrast to IL-3 dependent cell lines, (FI) cell lines failed to differentiate to mature granulocyte morphology in diffusion chambers in vivo. The FI cell lines formed no detectable CFUs in vivo, did not reconstitute hematopoiesis in irradiated mice and did not form tumors in vivo. The failure of the (FI) lines to form tumors and lack of detectable hematopoietic differentiation capacity indicates that these lines may represent an intermediate state between normally regulated hematopoietic cellular self-renewal and malignant transformation.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6431199     DOI: 10.1016/0145-2126(84)90076-6

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  6 in total

1.  Recent studies of the hematopoietic microenvironment in long-term bone marrow cultures.

Authors:  J S Greenberger; T J FitzGerald; P Anklesaria
Journal:  Immunol Res       Date:  1989       Impact factor: 2.829

2.  Characterization of membrane homing receptors in two cloned murine hemopoietic progenitor cell lines.

Authors:  T Matsuoka; C Hardy; M Tavassoli
Journal:  J Clin Invest       Date:  1989-03       Impact factor: 14.808

3.  Increased longevity of hematopoiesis in continuous marrow cultures and radiation resistance of marrow stromal and hematopoietic progenitor cells from caspase-1 homozygous recombinant-negative (knockout) mice.

Authors:  Michael Epperly; Hebist Berhane; Shaonan Cao; Donna Shields; Darcy Franicola; Julie P Goff; Xichen Zhang; Hong Wang; Robert Friedlander; Joel S Greenberger
Journal:  In Vivo       Date:  2013 Jul-Aug       Impact factor: 2.155

4.  Radioresistance of bone marrow stromal and hematopoietic progenitor cell lines derived from Nrf2-/- homozygous deletion recombinant-negative mice.

Authors:  Hebist Berhane; Michael W Epperly; Shaonan Cao; Julie P Goff; Darcy Franicola; Hong Wang; Joel S Greenberger
Journal:  In Vivo       Date:  2013 Sep-Oct       Impact factor: 2.155

5.  Differentiation stage and lineage-specific inhibitor from the stroma of mouse bone marrow that restricts lymphoma cell growth.

Authors:  D Zipori; M Tamir; J Toledo; T Oren
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

6.  Nuclear localization of v-Abl leads to complex formation with cyclic AMP response element (CRE)-binding protein and transactivation through CRE motifs.

Authors:  M C Birchenall-Roberts; F W Ruscetti; J J Kasper; D C Bertolette; Y D Yoo; O S Bang; M S Roberts; J M Turley; D K Ferris; S J Kim
Journal:  Mol Cell Biol       Date:  1995-11       Impact factor: 4.272

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.